CD4 and colorectal carcinoma: We observed a negative correlation between Alloprevotella and CD4 + T cells, suggesting that Alloprevotella may facilitate CRC progression by suppressing CD4 + T cell activity, which may be attributable to Alloprevotella-induced inflammation, which could disrupt epithelial barrier integrity and enhance bacterial translocation.